Article

Muscle spasms and spasticity constitute a significant problem in patients with
spinal cord injury, interfering with rehabilitation and leading to impairments in
quality of life in addition to medical complications. Administration of
intrathecal baclofen (ITB) is indicated when spasticity continues to produce a
clinical disability despite trials of oral treatments and other alternatives in
patients who have functional goals and/or pain without contractures. Severe
spasticity of spinal origin has been shown to respond dramatically to long-term
ITB when used in appropriate patients with spasticity.
CI - Copyright (c) 2014 Elsevier Inc. All rights reserved.

Langue : ANGLAIS